Global Biosimilars Insulin Market Is Expected to Witness a Steady Growth by 2024
Biosimilar insulin proved to have an effective treatment for patients suffering from diabetes mellitus by reducing the cost for the treatment. There are some companies who have developed devices which allow the safe and less painful delivery of biosimilar insulin thus making the device a market differentiator even though it's chemically equivalent to the branded product. Many companies in the emerging economies have started developing biosimilar insulin due to the favorable regulatory requirements as compared to the companies in developed...
View full press release